Converting from Nadolol to Propranolol
Use a 1:1 dose ratio when converting from nadolol to propranolol, but divide the total daily propranolol dose into 2-4 administrations per day since propranolol requires multiple daily dosing while nadolol is given once daily. 1
Conversion Protocol
Step 1: Determine Equivalent Daily Dose
- Convert nadolol to propranolol using a 1:1 ratio (e.g., nadolol 80 mg once daily = propranolol 80 mg total daily dose) 1
- Research demonstrates that in 60% of patients, the effective total daily dose of propranolol and nadolol was identical, with an overall dose ratio of 1.17:1 (propranolol to nadolol) across all patients 1
- However, individual dose titration is recommended because 40% of patients showed dosage variability when switching between these agents 1
Step 2: Divide Propranolol into Multiple Daily Doses
- Administer propranolol in 2-4 divided doses per day rather than once daily, as propranolol has a shorter duration of action compared to nadolol's inherently long duration 2, 1
- For immediate-release propranolol, the American College of Cardiology recommends 30-60 mg in divided doses with a maximum of 40-160 mg in divided or single dose with long-acting formulations 3
- Example conversion: Nadolol 80 mg once daily → Propranolol 40 mg twice daily (or 20 mg four times daily for immediate-release)
Step 3: Verify No Contraindications Before Switching
Check for absolute contraindications that apply to both agents 3, 4:
- AV block greater than first degree or SA node dysfunction without a pacemaker
- Decompensated systolic heart failure or cardiogenic shock
- Active asthma or reactive airway disease
- Hypotension (systolic BP <100 mmHg with symptoms)
Step 4: Initiate Propranolol with Monitoring
- Start propranolol the day after the last nadolol dose to avoid overlap, given nadolol's longer half-life 2
- Monitor blood pressure and heart rate at each visit during the transition 3
- Watch for bradycardia, hypotension, bronchospasm, and worsening heart failure as potential adverse effects common to both agents 3, 4
Step 5: Titrate Based on Clinical Response
- Adjust propranolol dose every 1-2 weeks based on blood pressure and heart rate response 3
- Target resting heart rate of 50-60 beats per minute unless limiting side effects occur 5
- Maximum propranolol dose is 160 mg daily in divided doses for most indications, though higher doses may be used in specific circumstances 3, 4
Critical Differences Between Nadolol and Propranolol
Pharmacokinetic Distinctions
- Nadolol is excreted entirely unchanged and not metabolized, while propranolol undergoes extensive hepatic metabolism 2
- Nadolol has a longer duration of action (12.2-hour half-life) allowing once-daily dosing, whereas propranolol requires multiple daily doses 2, 6
- Propranolol dosage may need reduction in patients with liver disease due to decreased drug clearance, while nadolol may be preferred in hepatic dysfunction 7
Shared Properties
- Both are nonselective beta-blockers without cardioselectivity 3, 2
- Both demonstrate comparable efficacy in controlling hypertension and angina 8, 1
- Both have similar adverse effect profiles including hypotension, bradycardia, and bronchospasm 3, 4
Common Pitfalls to Avoid
- Never abruptly discontinue nadolol before starting propranolol, as this can precipitate rebound hypertension, exacerbation of angina, myocardial infarction, and ventricular arrhythmias 7, 4
- Do not assume a simple 1:1 conversion will work for all patients—40% showed dosage variability requiring individual titration 1
- Avoid using propranolol in pre-excited atrial fibrillation, as it may precipitate very rapid ventricular rates 4
- Do not combine propranolol with other AV nodal blocking agents (calcium channel blockers, digoxin) without careful monitoring, as profound bradycardia can develop 3
- In diabetic patients, recognize that propranolol masks hypoglycemia symptoms and requires extreme caution 4
Special Populations
Patients with Liver Disease
- Propranolol requires dose reduction in hepatic impairment due to decreased clearance 7
- Avoid doses >160 mg/day total in decompensated cirrhosis, as higher doses are associated with worse survival outcomes 4